Mutational and expression analysis of classical protein tyrosine phosphatase genes in pancreatic ductal adenocarcinoma

This publication has 24 references indexed in Scilit:

• PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target
  Journal of Cancer Research and Clinical Oncology, 2023
• E3 Ubiquitin Ligase MARCH8 Promotes Pancreatic Cancer Growth and Metastasis by Activating STAT3 via Degradation of PTPN4
  Pancreas, 2023
• The role of receptor‐type protein tyrosine phosphatases in cancer
  Precision Medical Sciences, 2023
• Inhibition of PTPN21 has antitumor effects in glioma by restraining the EGFR/PI3K/AKT pathway
  Toxicology and Applied Pharmacology, 2022
• P-235 Elevated protein tyrosine phosphatase kappa expression is associated with disease progression and poor prognosis of pancreatic cancer
  Annals of Oncology, 2022
• Proteogenomic characterization of pancreatic ductal adenocarcinoma
  Cell, 2021
• PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor
  Translational Oncology, 2021
• Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer
  Cancer Science, 2019
• Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma
  Cellular and Molecular Life Sciences, 2019
• A missense variant in PTPN12 associated with the risk of colorectal cancer by modifying Ras/MEK/ERK signaling
  Cancer Epidemiology, 2019